Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
193
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study

Chad Moretz1 US Value Evidence and Outcomes, GSK, Durham, NC, USACorrespondence[email protected]
,
Lucie Sharpsten2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA
,
Lindsay GS Bengtson2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA
,
Eleena Koep2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA
,
Lisa Le2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA
,
Junliang Tong2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA
,
Richard H Stanford1 US Value Evidence and Outcomes, GSK, Durham, NC, USA
,
Beth Hahn1 US Value Evidence and Outcomes, GSK, Durham, NC, USA
&
Riju Ray3 US Medical Affairs, GSK, Durham, NC, USA
 show all
Pages 1721-1737 | Published online: 01 Aug 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.